Clinical Trial: Single-Arm Clinical Study of EZH2i in Combination With Glofitamab + GemOx in Patients With Relapsed/ Refractory DLBCL

U.S., June 13 -- ClinicalTrials.gov registry received information related to the study (NCT07643805) titled 'Single-Arm Clinical Study of EZH2i in Combination With Glofitamab + GemOx in Patients With Relapsed/ Refractory DLBCL' on June 04.

Brief Summary: Single-Arm Clinical Study of Zeprumetostat in Combination with Glofitamab + GemOx in Patients with Relapsed/ Refractory DLBCL

Study Start Date: June 01

Study Type: INTERVENTIONAL

Condition: DLBCL

Intervention: DRUG: EZH2i+GLofit-GemOx

EZH2i+GLofit-GemOx

Recruitment Status: NOT_YET_RECRUITING

Sponsor: The First Affiliated Hospital with Nanjing Medical University

Information provided by (Responsible Party): Lei Fan, The First Affiliated Hospital with Nanjing Medical University

Pub...